SELECTED MEDIA References
Londoño E. "A Psychedelic Renaissance at the V.A.". New York Times. 06/24/2022.
Londoño E. "After Six-Decade Hiatus, Experimental Psychedelic Therapy Returns to the V.A.". New York Times. 06/24/2022.
Lee YJ & Schuster-Bruce C. "The 18 power players shaping the future of the first legal magic-mushroom market in the US". Business Insider. 06/15/2022.
Cooper L. “Could group therapy get a boost from psychedelics?". WSJ. 03/10/2021.
Selksy A. “2 drug measures on Oregon ballot". Associated Press. 10/16/2020.
Doyle B. “Oregon could herald a research-driven psychedelic renaissance”. The Oregonian. 09/05/2020.
Holland J. (2020). “Good Chemistry: The Science of Connection from Soul to Psychedelics”. Harper Wave. New York, NY.
Hartman S. “Where are All the Queer People?”. DoubleBlind Mag. 10/28/2019.
SELECTED
Presentations
Stauffer CS & Kachmarik J. (2022). “Psychedelic Research in the Pacific Northwest”. Horizons NW: Perspectives on Psychedelics. Portland, OR.
Stauffer CS. (2021). "Psychedelic Therapy: The Science and Safety of Psilocybin". Oregon Health & Science University, Brain Awareness Lecture Series.
Stauffer CS. (2021). "Psilocybin-Assisted Psychotherapy". Oregon Health & Science University, Dept. of Psychiatry Grand Rounds.
Stauffer CS. (2020). “MDMA-Assisted Psychotherapy for PTSD: Are We Nearing FDA Approval?”. Oregon Psychiatric Physicians Association (OPPA) 2020 Winter Meeting.
Stauffer CS. (2019). “Examining the Queer Communities’ Healing Edge: Reflections on a Clinical Trial of Oxytocin-Enhanced Group Therapy for Methamphetamine Users”. Queering Psychedelics. San Francisco, CA.
Stauffer CS, Johnson M, Cosimano M. (2019). “Psychedelics in Addiction Treatment”. The Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) annual conference. Boston, MA.